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Abstract
Background: Cinnamon has been shown to delay gastric emptying of a high-carbohydrate meal and reduce
postprandial glycemia in healthy adults. However, it is dietary fat which is implicated in the etiology and is
associated with obesity, type 2 diabetes and cardiovascular disease. We aimed to determine the effect of 3 g
cinnamon (Cinnamomum zeylanicum) on GE, postprandial lipemic and glycemic responses, oxidative stress, arterial
stiffness, as well as appetite sensations and subsequent food intake following a high-fat meal.
Methods: A single-blind randomized crossover study assessed nine healthy, young subjects. GE rate of a high-fat
meal supplemented with 3 g cinnamon or placebo was determined using the 13C octanoic acid breath test.
Breath, blood samples and subjective appetite ratings were collected in the fasted and during the 360 min
postprandial period, followed by an ad libitum buffet meal. Gastric emptying and 1-day fatty acid intake
relationships were also examined.
Results: Cinnamon did not change gastric emptying parameters, postprandial triacylglycerol or glucose
concentrations, oxidative stress, arterial function or appetite (p < 0.05). Strong relationships were evident (p < 0.05)
between GE Thalf and 1-day palmitoleic acid (r = -0.78), eiconsenoic acid (r = -0.84) and total omega-3 intake (r =
-0.72). The ingestion of 3 g cinnamon had no effect on GE, arterial stiffness and oxidative stress following a HF
meal.
Conclusions: 3 g cinnamon did not alter the postprandial response to a high-fat test meal. We find no evidence
to support the use of 3 g cinnamon supplementation for the prevention or treatment of metabolic disease. Dietary
fatty acid intake requires consideration in future gastrointestinal studies.
Trial registration: Trial registration number: at http://www.clinicaltrial.gov: NCT01350284
Keywords: gastrointestinal, antioxidant capacity, obesity, type 2 diabetes, polyphenols, fatty acids, omega-3 fatty
acids
Background
Free-living individuals are in the postprandial hyper-tri-
glyceridemic state for the majority of a 24-h period [1].
Dietary supplementations, such as traditional spices,
that can limit lipemia and glycemia in the fed state,
have important implications for prevention and manage-
ment of metabolic diseases. Two decades ago, cinnamon
(Cinnamomum zeylanicum) was proposed as a treat-
ment for type 2 diabetes (T2D) when it was shown to
display insulin-mimetic properties [2]. Cinnamon has
been proposed to act on numerous mechanisms relating
to glucose and insulin function including improved cel-
lular uptake of glucose through stimulation of insulin
receptor kinase activity, increased insulin receptor phos-
phorylation and glycogen synthesis activity and reducing
inflammation through antioxidant effects [3-7]. Chronic
supplementation of 1 to 6 g cinnamon has been shown
to have similar effects with regards to lowering of
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fasting glucose and lipid levels in diabetic patients [8].
Acutely, a 5 g cinnamon bolus improved glycemic
responses and insulin sensitivity when given 12 hours
prior to, or with, an oral glucose tolerance test (OGTT)
in healthy adults [9].
In addition to rate of glucose removal from circula-
tion, plasma glucose concentration is also determined by
the rate of glucose entering the circulation [10]. Gastric
emptying (GE) is an important determinant of rate of
glucose appearance and blood glucose homeostasis in
healthy and diabetic populations [11,12]. Delayed GE
could be part of the mechanism by which cinnamon
improves glucose tolerance. When combined with a
semi-solid, low-fat meal, 6 g cinnamon reduced post-
prandial glycemia and delayed GE in healthy subjects
[13].
Vascular dysfunction has emerged as a critical step in
the development and progression of CVD, specifically
atherosclerosis [14]. Vascular dysfunction refers to
impairments in nitric oxide (NO)-mediated endothe-
lium-dependent dilation, which is inversely related to an
increase in vessel stiffness [15]. These impairments may
stem from decreased NO synthesis and/or release, in
combination with exaggerated consumption by reactive
oxygen species (ROS) [16]. It has been postulated that
postprandial lipemia may promote vascular dysfunction
via an oxidative stress pathway [17-19].
The actions of dietary fatty acids on the gastrointest-
inal (GI) tract are still poorly understood. Acute inges-
tion of dietary fat can potently delay GE and reduce
appetite [20]; these effects are partly mediated by the
secretion of GI peptides including glucagon-like pep-
tide-1 (GLP-1) and cholecystokinin (CCK) [21]. Dietary
fatty acid intake may be one factor that affects inter-
and intra- subject variability in GE rates.
We aimed to determine if acute supplementation of 3
g cinnamon would reduce postprandial glycemic and
lipemic responses to a high-fat (HF) meal through a
delay in GE or an alternative mechanism. We also eval-
uated the effect of cinnamon ingestion on oxidative
stress, vascular function, appetite sensations and subse-
quent food intake in healthy subjects. Additionally, we
examined the relationship between previous day fatty
acid intake and GE of the HF test meal.
Methods
Subjects
Nine apparently healthy subjects (3 male, 6 female; age
26.2 ± 3 years; mass 66.5 ± 11.3 kg; BMI 22.4 ± 2.5 kg/
m2; body fat 22.2 ± 6.5%) consented to participate in
the study, which was approved by the Local Research
Ethics Committee. Subjects had no history of GI-related
complaints, CVD or diabetes and were not currently
taking antioxidant or lipid-lowering medication. Subjects
were non-smokers and were recreationally active (per-
forming < 60 min of moderate to intense exercise per
day, on every day of the week) determined using a 3
month exercise questionnaire. Fasting blood lipid, glu-
cose and blood pressure (BP) levels were all within the
normal limits. Subjects were required to rate at least
50% of the food items that would be presented in the
buffet meal as 5 or higher in a food preference question-
naire for study inclusion. Two subjects were identified
as restrained eaters (scoring > 12 on the eating restraint
section (factor 1) of the Three-Factor Eating Question-
naire [22]).
Experimental design
Each subject completed two separate 1-day trials sepa-
rated by 28 days: cinnamon and placebo (wheat flour)
supplementation. Trials were conducted in a single-
blind, placebo controlled randomized fashion and were
identical apart from the content of the capsules. During
the 3 d before the first trial, subjects recorded all of the
food and drink that they consumed and repeated this
diet before the second trial. Energy, macronutrient and
fatty acid intake were calculated using CompEat Pro
Nutritional Analysis software (Version 5.8; Nutrition
Systems, Grantham, UK). Physical activity was also
logged during this time period. Subjects were instructed
to minimize their consumption of foods with naturally
high 13C abundance on the day preceding each trial and
were asked to refrain from alcohol consumption and
vigorous exercise. Apart from these requirements, sub-
jects ate and exercised ad libitum between the two test-
ing periods.
Study day protocol
Subjects reported to the laboratory after a 12 h over-
night fast. Following 15 min interval of supine rest, mea-
surements of arterial stiffness (see measurements) and
BP were obtained and a baseline blood sample was col-
lected. Subjects returned to the seated position and after
a 10 min interval, baseline breath samples were taken
and visual analogue scale (VAS) questionnaires were
completed (t = -15 and -10 min). Once baseline mea-
surements were taken, subjects consumed the test meal
within 15 min (see below). Upon completion of the
meal (t = 0 min), sequential postprandial measurements
of GE, appetite sensations, arterial stiffness, BP and
plasma glucose and lipids responses were taken. Expired
breath samples were collected at t = 0 min, every 5 min
for the first half hour after meal consumption and there-
after in 15-min intervals from t = 30 until 360 min for
the detection of 13CO2 (see measurements). VAS ques-
tionnaires were administered after consumption of
breakfast (t = 0 min) and every 30 min until t = 360
min. Arterial stiffness, BP measurements and blood
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samples were collected hourly from t = 60 to t = 270
min (t = 240 min for blood samples). At the end of
postprandial assessments (t = 360 min), subjects were
presented with an assortment of cold lunch-type buffet
foods. The meal comprised of six slices of wholegrain
bread (235 g), six slices of white bread (235 g), 115 g
sliced ham, 115 g sliced chicken, 100 g grated cheddar
cheese, 60 g lettuce, 125 g cherry tomatoes, 80 g sliced
cucumber, 90 g sweet corn, 100 g coleslaw, 30 g butter,
30 g mayonnaise, 30 g relish, 415 g strawberry yoghurt,
6 biscuits (75 g), 120 g chocolate Swiss roll, 60 g crisps
and 300 ml water. The total energy content of the buffet
meal was 16504 kJ. The selection presented was in
excess of anticipated consumption. Subjects were given
30 min (i.e. t = 360 - 390 min) to eat ad libitum until
‘comfortably full’. After ingestion of the buffet meal,
subjects completed another VAS questionnaire and were
then free to leave the laboratory. Additional VAS ques-
tionnaires were administered after consumption of the
test meal and buffet meal (t = 0 and 390 min) to evalu-
ate meal palatability as well as sensations of nausea and
well-being. They recorded their subsequent food intake
for the remainder of the test day.
Test meal
The test meal consisted of three pancakes (36 g flour, 44
g egg, 70 g whole milk, 30 g sunflower oil) served with
20 g chocolate spread and 300 ml of water. The test
meal was enriched with 150 μl 13C octanoic acid (Cam-
bridge Isotope Laboratories, Andover, MA, USA), which
was solubilized in the egg yolk prior to cooking. After
homogenizing the yolk, it was mixed with the other
ingredients to ensure uniform distribution of the label
throughout the pancake batch. The test meal provided
2646 kJ of energy and consisted of 42 g carbohydrate,
46 g fat and 13 g protein. Subjects were instructed to
ingest 8 gelatin capsules (four directly before and after
meal) totaling 3 g Cinnamon powdered spice (Cinnamo-
mum zeylanicum; Schwartz, UK) or a wheat flour pla-
cebo (Odlums, Ireland).
Measurements
Gastric emptying
Gastric emptying was determined using the 13C octanoic
acid breath test [23,24]. Breath samples were collected
into 10 ml tubes (Exetainers; Labco, Bucks, UK). The
analysis of the 13CO2/
12CO2 enrichment in breath sam-
ples was performed using an ABCA (Europa Scientific,
Crewe, UK) isotope ratio mass spectrometer. GE para-
meters, gastric half emptying time (Thalf), lag phase
(Tlag), latency time (Tlat) and ascension time (Tasc) were
calculated using previously described methods [23,25].
Cumulative excretion of 13CO2 (as a percent of ingested
dose) was also calculated.
Arterial stiffness
Arterial stiffness was measured using the PulseTrace
PCA 2 device (Micro Medical, Kent, UK). The device
measures the digital volume pulse (DVP) through the
use of a photoplethysmographic transducer placed on
the index finger of the right hand, transmitting infra-red
light at 940 nm. The device permits the calculation of
the stiffness index (SI; m/s) and the reflection index (RI;
%) [26,27]. Heart rate (HR) in beats/min (bpm) was also
measured by transmission of the DVP.
Blood pressure
Systemic arterial blood pressure (BP) was measured at the
brachial artery using an Omran M5-I fully automatic BP
monitor (Surrey, UK). Measurements were taken in triplicate
directly after arterial stiffness measurements in the supine
position and an average of these readings was recorded.
Blood analyses
Blood samples were collected into K-EDTA and NaF tubes
and placed on ice. Serum separating clot activator tubes
were allowed to clot at room temperature. All samples were
separated within 30 min of collection and stored at -70°C
until analysis. Plasma glucose was determined by an immo-
bilized enzyme membrane method in conjunction with a
Clark electrode on a YSI 2300 analyzer (Yellow Springs,
USA). Total cholesterol, TAGs and HDL were measured by
enzyme assay kits, using an automated analyzer (Aeroset
™, Abbott Labs, USA [28]). LDL cholesterol was calculated
using the Friedewald equation [29]. All samples for each
subject were analyzed in a single analyzer run. CVs were <
7.7% for glucose and < 10.0% for all blood lipids.
Serum lipid hydroperoxides
Serum lipid hydroperoxides (LOOHs) (as measures of
lipid peroxidation) were incubated with FOX-1 assay
and quantified using a Shimadzu UV-VIS 1240 Spectro-
photometer, (Mason Technology, Belfast, Northern Ire-
land [28]. CV was < 16% for LOOH.
Appetite sensations and subsequent energy intake
Sensations of hunger, desire to eat, fullness, thirst, tired-
ness and coldness were assessed using a VAS question-
naire [30]. Although it was important to examine general
well being, the latter sensations were primarily included
so that subjects were unaware that our primary outcome
measures were sensations of appetite. Each VAS assessed
a sensation on a 150 mm horizontal line anchored at the
beginning and end by opposing statements.
The quantity of food consumed in the buffet meal was
recorded to the nearest 0.1 g and the total energy (kJ)
and macronutrient intakes (% of energy) were subse-
quently calculated. Time taken to complete the buffet
meal completion (in min) was also recorded.
Statistics
Data were checked for normal distribution before sta-
tistical analysis was preformed. Appetite sensation data
Markey et al. Cardiovascular Diabetology 2011, 10:78
http://www.cardiab.com/content/10/1/78
Page 3 of 9
was transformed by natural log. Fasting measurements
of arterial stiffness, blood pressure and plasma lipid
and glucose concentrations were calculated as the
mean of the values collected at baseline (~t = -30 to
-20 min). Baseline GE and appetite sensation scores
were calculated as the mean of values collected at t =
-15 and -10 min. Blood biomarkers, appetite sensations
and arterial stiffness data were analyzed using a two-
way (time × supplement) repeated-measures ANOVA.
Incremental area under the glycemic curve (IAUC) was
calculated using the trapezoidal rule by subtracting
baseline values from measured plasma glucose concen-
trations. Relationships between variables were com-
pared using Pearson correlations. Paired-sample t tests
were used to compare GE parameters, habitual diet,
physical activity intensity and duration as well as food
intake at the buffet meal (quantity, energy consumed
and macronutrient distribution). Statistical significance
was established at the p < 0.05 level and the mean
values ± SD are reported. All statistical analyses were
carried out using SPSS-version 16.0 (SPSS, Inc., Chi-
cago, IL, USA). Power calculation was conducted for
gastric emptying Thalf the primary endpoint evaluation.
A sample size of 9 subjects was necessary to detect a
15.8% change in GE rate [13] in a two-sided paired
Students’ t-test with alpha set at 5% and a power of
80%. Trial registration number: at http://www.clinical-
trial.gov: NCT01350284.
Results
Test days were well tolerated by all subjects. Subjects
successfully repeated their food and physical activity dia-
ries as indicated by no significant differences in energy
or macronutrient intake (p > 0.05) and in total and
exercise intensities respectively (p > 0.05) for 3 days
prior to each treatment. Usual dietary intake was consis-
tent with guidelines for healthy living (51% of energy
from carbohydrate, 31% fat, and 18% protein).
Gastric Emptying
No significant effect of cinnamon supplementation was
observed on gastric emptying parameters (Table 1).
Cardiovascular Measures
Arterial stiffness
There were no mean differences between or within the
groups for SI (time × supplement interaction, p > 0.05)
(Table 2). However, a main effect for time was observed
whereby SI decreased postprandially in both supple-
ments (pooled placebo and drug data, p < 0.05). There
were no reported differences either between or within
supplements for RI over time following the ingestion of
the test meal (time × supplement interaction, p > 0.05)
(Table 2).
Blood pressure and heart rate
There were no differences either between or within the
groups for both systolic and diastolic BP over time fol-
lowing the ingestion of the test meal (time × supple-
ment interaction, p > 0.05). There were no mean
differences between or within the groups for HR (time ×
supplement interaction, p > 0.05). However, a main
effect for time was observed whereby HR decreased over
time across both trials (60 ± 10 bpm at baseline vs. 52 ±
Table 1 Mean values for gastric emptying parameters
and food intake from the buffet meal after the ingestion
of high-fat meal supplemented with 3 g wheat flour
(placebo) or cinnamon
Variable Placebo Cinnamon
Gastric emptying
Thalf (min) 237 ± 32 245 ± 49
Tlag (min) 136 ± 12 143 ± 22
Tlat (min) 40 ± 6 43 ± 9
Tasc (min) 197 ± 35 202 ± 48
Cumulative excretion of13CO2 (%) 55.1 ± 10.0 56.3 ± 4.9
Food intake
Energy intake (kJ) 3056 ± 1130 3324 ± 1516
Quantity consumed (g) 420 ± 200 467 ± 151
Carbohydrate (%) 40 ± 13 43 ± 12
Fat (%) 40 ± 8 36 ± 10
Protein (%) 21 ± 10 22 ± 9
Time (min) 15 ± 3 15 ± 5
Thalf, gastric half emptying time; tlag, lag phase; tasc, ascension time; tlat,
latency time.
Data are means ± SD, n = 9.
No significant differences were found between treatments, p > 0.05.
Table 2 Mean stiffness and reflection index values after
the ingestion of high-fat meal supplemented with 3 g
wheat flour (placebo) or cinnamon
Variable Placebo Cinnamon
Stiffness Index (m/sec)
Baseline 5.58 ± 0.55 5.78 ± 0.48
60 min 5.53 ± 0.49 5.46 ± 0.51
120 min 5.42 ± 0.44 5.32 ± 0.46
180 min 5.39 ± 0.41 5.34 ± 0.71
240 min 5.34 ± 0.32 5.31 ± 0.36
300 min* 5.47 ± 0.45 5.19 ± 0.41
Reflection Index (%)
Baseline 68.92 ± 18.15 68.72 ± 21.42
60 min 61.26 ± 12.73 60.15 ± 12.19
120 min 61.64 ± 8.79 63.76 ± 8.92
180 min 66.74 ± 12.63 69.37 ± 12.49
240 min 71.57 ± 15.84 69.70 ± 8.88
300 min 69.78 ± 12.99 68.68 ± 12.71
Data are means ± SD, n = 9.
No significant differences were found between treatments, p > 0.05. * Main
effect for time for Stiffness Index; pooled placebo and drug data, p < 0.05
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9 bpm at 300 min post meal in placebo trial; 61 ± 12
bpm at baseline vs. 51 ± 9 bpm at 300 min post meal in
cinnamon trial; pooled placebo and drug data, p < 0.05).
Blood biomarkers
Plasma glucose
Baseline plasma glucose concentrations tended to be
higher after cinnamon supplementation compared to
placebo (p > 0.05; n = 8 for all blood derived measure-
ments). Plasma glucose concentrations changed across
time in response to both supplementations (p < 0.0001)
(Figure 1). There was no significant interaction between
time and supplement (p > 0.05). Three hours after meal
ingestion all plasma glucose concentrations were similar
to baseline concentrations, regardless of supplement.
IAUC following placebo (-22.2 ± 87.6 mmol/l/min) was
similar to that following cinnamon ingestion (-14.2 ±
29.1 mmol/l/min, p = 0.819).
Plasma lipids
Baseline plasma TAG, total cholesterol, HDL and LDL
concentrations did not differ significantly between trials
(Table 3). There were no changes in TAG between trials
(time × treatment interaction, p > 0.05) but there was a
main effect for time (pooled placebo and cinnamon
data, p < 0.05). There were no changes in plasma total
cholesterol, HDL, or LDL levels either within or
between the trials (time × supplement interaction; p >
0.05).
Serum lipid hydroperoxides
There was a main effect for time for LOOHs with levels
increasing over time throughout the course of the trials
(pooled placebo and cinnamon data, p < 0.05) but there
were no changes in mean LOOHs between or within
the groups (time × supplement interaction, p > 0.05)
(Figure 2).
Appetite sensations and subsequent energy intake
The variables thirst, tiredness and coldness did not vary
significantly with supplementation or over time (data
not shown). Baseline appetite sensation VAS scores did
not differ significantly between conditions. Changes to
appetite sensation scores were evident over time after
ingestion of test meals (p < 0.05). No significant effect
of treatment was observed on sensations of hunger (Fig-
ure 3), desire to eat and fullness (data not shown). No
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Figure 1 Plasma glucose concentrations in healthy subjects
after the ingestion of a high-fat test meal supplemented with
3 g cinnamon or placebo. Values are means, with standard
deviations represented by vertical bars (n = 8).
Table 3 Mean plasma lipid values after the ingestion of
high-fat meal supplemented with 3 g wheat flour
(placebo) or cinnamon
Variable Placebo Cinnamon
TAG (mmol/l)
60 min 0.84 ± 0.27 0.80 ± 0.32
120 min 0.93 ± 0.36 0.88 ± 0.32
180 min 1.01 ± 0.36 0.95 ± 0.37
Total Cholesterol (mmol/l)
60 min 3.80 ± 0.59 3.93 ± 0.43
120 min 3.79 ± 0.55 3.77 ± 0.68
180 min 3.85 ± 0.52 3.78 ± 0.69
HDL (mmol/l)
60 min 1.45 ± 0.31 1.49 ± 0.41
120 min 1.39 ± 0.27 1.46 ± 0.38
180 min 1.45 ± 0.32 1.45 ± 0.36
LDL (mmol/l)
60 min 1.97 ± 0.57 2.07 ± 0.30
120 min 1.98 ± 0.54 1.91 ± 0.48
180 min 1.92 ± 0.46 1.90 ± 0.41
Data are means ± SD, n = 9.
No significant differences were found between treatments, p > 0.05.
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Figure 2 Lipid hydroperoxides (LOOHs) concentrations in
healthy subjects before and after the ingestion of a high-fat
test meal supplemented with 3 g cinnamon or placebo. Values
are means, with SD represented by vertical bars (n = 8).
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differences between sensations of palatability, pleasant-
ness, nausea and stomach pain recorded when treat-
ments were compared after the test breakfast (t = 0
min) and buffet-style lunch meal (t = 390 min). No sig-
nificant effect of treatment was observed for quantity of
food consumed, energy intake, percentage of energy
provided by carbohydrate, fat or protein and time taken
to consume the buffet meal (Table 1).
Relationship between variables
Significant positive correlations were observed between
TAG levels and LOOHs (r = 0.52, p < 0.0001) and SI
and LOOH (r = 0.24, p < 0.05). GE Thalf was inversely
related to energy intake in the buffet meal after cinna-
mon ingestion (r = -0.67, p < 0.05) but not in the pla-
cebo trial (r = -0.62, p > 0.05).
Relationship between gastric emptying and 3-day
background fatty acid intake
No significant differences were observed between 1-day
background fatty acid intake before cinnamon and pla-
cebo trials. 1-day intake of palmitoleic acid (C16:1, r =
-0.78, p < 0.05), eiconsenoic acid (C20:1, r = -0.84, p <
0.01) and total n-3 intake respectively (r = -0.72, p <
0.05) were inversely related to GE Thalf of the placebo-
supplemented HF meal (Table 4). 1-day intake of C16:1,
C20:1 and total n-3 fatty acids accounted for 61, 71 and
51% of the variance in GE Thalf respectively. No signifi-
cant relationships between GE Thalf after cinnamon
ingestion and 1-day of palmitoleic acid, eiconsenoic acid
or total n-3 intake were observed (p > 0.05).
Discussion
The current study tested the hypothesis that supple-
menting a single HF breakfast with 3 g of cinnamon
would delay GE of a high-fat solid meal utilizing the 13C
octanoic acid breath test, and consequently reduce post-
prandial blood glucose and lipid concentrations.
Gastric Emptying, Metabolic Variables and Appetite
We were unable to induce significant changes in GE
using 3 g of cinnamon. The test meal (65% of energy
from fat) was mainly from sunflower oil, which contains
approximately 70% linoleic acid (C18:2n-6, a PUFA
[31]). Long-chain fatty acids have a potent inhibitory
effect on GE rate [20,32] and have also been shown to
increase CCK and GLP-1 concentrations [21]. We pro-
pose that cinnamon does not delay GE over and above
the effects of the fat content of the meal. Furthermore,
we found similar postprandial glycemic and lipemic
responses under both conditions. However, it should be
noted that we were unable to measure a hyperglycemic
or hyperlipidemic state. Studies which employed the lar-
gest doses of cinnamon relative to carbohydrate in the
test meal (carbohydrate/cinnamon ratio of 15 or lower
[9,13]) appear to have had the most potent effects on
reducing postprandial glycemia [33]. In spite of the cur-
rent high ratio of 14, we did not achieve a significant
blood glucose-lowering effect. This is possibly due to
glucose absorption from the small intestine being
affected by the fat content of a meal [34].
Recent data indicates that the addition of 3 g cinna-
mon to a low-fat rice pudding test meal had no signifi-
cant effect on GE rate or postprandial glycemia in
healthy individuals [35]. However, cinnamon did signifi-
cantly lower serum insulin levels and increase GLP-1
concentrations, a GI peptide which has been shown to
increase glucose-dependent secretion of insulin, delay
GE and reduce glucose absorption and postprandial gly-
cemia [36,37]. When added to the same test meal, 6 g
cinnamon significantly delayed GE and reduced post-
prandial glycemia but the decrease in blood glucose
concentration was more apparent than the delay in GE
rate suggesting that GE cannot be the sole mechanism
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Figure 3 Visual analogue scale (VAS) scores for sensations of
hunger in healthy subjects before and after the ingestion of a
high-fat test meal supplemented with 3 g cinnamon or
placebo (n = 8). * Represents the time immediately after breakfast.
Values are means, with SD represented by vertical bars.
Table 4 Relationship between previous day reported
intake of fatty acids (1-day) and GE Thalf of high-fat meal
supplemented with 3 g wheat flour (placebo) or
cinnamon (n = 9)
Placebo r Cinnamon r
Energy (kJ) 7963 ± 871 -0.55 8210 ± 1599 0.08
Fat (g) 63.46 ± 12.39 -0.22 72.96 ± 24.67 0.43
16: 1 (g) 0.29 ± 0.17 -0.78 † 0.31 ± 0.14 -0.53
20: 1 (g) 0.11 ± 0.12 -0.84 †† 0.15 ± 0.18 -0.29
Total n-3 (g) 0.48 ± 0.37 -0.72 † 0.55 ± 0.40 -0.54
Thalf, gastric half emptying time; C16:1, palmitoleic acid; C18:1n-9, oleic acid;
C20:1,eiconsenoic acid; total n-3, total omega-3 intake.
Data are means ± SD, n = 9.
Correlations were significantly different: † = p < 0.05, †† = p < 0.01.
Markey et al. Cardiovascular Diabetology 2011, 10:78
http://www.cardiab.com/content/10/1/78
Page 6 of 9
explaining lower blood glucose responses following cin-
namon ingestion [13]. Agreeing with the findings of
others [13,33,34], we found that cinnamon did not influ-
ence appetite sensations or subsequent food intake,
probably as a result of similar GE rates between condi-
tions [38]. Together with data presented in the current
study, cinnamon is unlikely to be relevant in affecting
the postprandial response to HF meals.
Diet and fatty acid intake
Assessment of previous day dietary intake indicated that
a higher intake of C16:1, C20:1 and total n-3 was asso-
ciated with a shorter GE Thalf of the HF meal supple-
mented with the wheat flour placebo. To our
knowledge, this is the first observation of specific dietary
fatty acids from preceding diet affecting GI transit in
humans. A single meal, supplemented with n-3 PUFAs,
was less capable of triggering GLP-1 and CCK com-
pared to other fats, resulting in a more rapid GE of a
HF breakfast [39] while others showed that n-3 PUFA
fish oil reduced CCK release and gallbladder contraction
without affecting GE [40]. Both GLP-1 and CCK are
putative mediators of the ileal brake, a feedback
mechanism responsible for delaying transit and facilitat-
ing digestion, in response to lipids in the distal GI tract
[41]. Our current findings extend these observations to
illustrate that even short-term intake of n-3 fatty acids is
associated with faster GE rates, in a population who
were not eating a HF diet. This means that mechanisms
apart from acute release of GLP-1 and CCK, must med-
iate the effects of specific fatty acids on GI transit.
Recently, a 3-day HF yoghurt supplementation, rich in
C18:2n-6 accelerated the GE rate of a test meal rich in
the same fatty acid [42]. It is interesting to note that
background intake of C18:2n-6, which was high in the
test meal, did not show a strong association with GE of
the meal. Our observations suggest that GE Thalf of a
HF meal is not just specifically affected by a background
intake of that specific fatty acid and that the process of
adaptation to a HF diet may involve mechanisms other
than desensitization to a specific fatty acid. It is likely
that different adaptations are continuously taking place
in the gut, in response to the balance of fatty acids in
the diet. It is tempting to speculate about the potential
mechanisms for fat sensing and adaptation following the
recently sequenced GPR120 protein, expressed on
intestinal cells, and demonstrated to be differentially
sensitive to different fatty acids [43].
Vascular Function and antioxidant capacity
One of the principle findings of this study was that no
changes were observed in relation to the measures of
vascular function. Interestingly, there was a main effect
for time indicating a decrease in SI which at face value
appears paradoxical given the transient impairment in
vessel function following the ingestion of a HF meal
[44,45]. This apparent contradiction might be explained
by the fact the test meal we used may not have been of
sufficient energy and, in particular, fat content to evoke
a change in vessel function. In most of the related litera-
ture the postprandial TAG concentration associated
with vascular dysfunction (~2.0 mmol/l; [17,18,44]) is
double than that presently observed. Moreover, the HF
meal in the current study contained 297 - 1742 kJ less
energy (and 14 - 34 g less fat) than other similarly
designed investigations [17,45-47]. Such discrepancies in
meal composition further highlight the need for a stan-
dardized, physiologically relevant HF meal [48] to be
used in future corresponding studies, similar to the
OGTT.
Due to its polyphenolic nature, cinnamon is thought
to exhibit antioxidant properties [3,49] which may be
anti-atherogenic. It is proposed that the impairments in
blood vessel function following the ingestion of HF
loads are perpetrated via an oxidative stress mechanism
that can increase the unwanted consumption of NO and
favor the formation of further ROS, such as peroxyni-
trite (ONOO-) [17-19,28,44]. In the present study cinna-
mon ingestion had no apparent effect on indices of
oxidative stress as a main effect for time was observed
for LOOHs.
It has been documented that even high-normal fasting
glucose levels can aggravate arterial stiffness [50] but
when cinnamon was added to rats fed a high-fat high-
fructose diet hepatic glycogen, hepatic insulin receptors
and glut4 transporter in muscle tissue all increased [51].
Despite no reported change in arterial stiffness using
our physiologically relevant high-fat meal, the possibility
therefore exists that cinnamon could modulate stiffness
by affecting (hepatic) glycemic control and thus this
relationship merits further scrutiny.
Emerging research postulates the existence of a diur-
nal variation in endothelial function [52]. Fluctuations in
the competitive balance between intrinsic local vasodila-
tor function and sympathetic nervous system (SNS) a-
adrenoreceptor-mediated vasoconstriction have recently
been proposed as one potential mechanism to explain
such findings [53]. Given the conceptual relationship
between endothelial function and arterial stiffness, and
the observed main effect for a decrease in HR (as an
indirect measure of SNS activity), it is tempting to spec-
ulate that this explanation may in some way account for
the SI data in the current investigation. Conversely, this
was tempered by the fact that no changes in RI were
recorded.
This study may have been underpowered and there-
fore a small effect below the detection threshold of the
study cannot be ruled out. Three grams of cinnamon
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was used as because it was shown to have a similar
chronic effect on fasting serum glucose and lipid profiles
as 6 g [8]. However, recent evidence suggests a dose-
dependent relationship for cinnamon consumed and the
delay in GE [13,35].
Conclusions
We found no evidence for delayed GE rate or reduced
indices of oxidative stress in response to a HF meal sup-
plemented with 3 g cinnamon compared to placebo.
Cinnamon did not change postprandial glycemic and
lipemic responses, arterial stiffness or appetite. Given
the association between 1-day fatty acid intake and GE
Thalf, we suggest that controlling for background fatty
acid composition requires consideration in future gas-
trointestinal studies.
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